Abstract: With continuous advancement in oncology therapeutics, various anti-cancer treatment strategies have significantly improved the survival rates of cancer patients. However, cancer treatment-related cardiovascular toxicity has emerged as a critical issue that cannot be overlooked. It has been a shared objective of oncology and cardiology specialists to perform personalised dynamic monitoring of cardiovascular toxicity for cancer patients, to provide safe and effective oncology treatment, to provide long-term care for patients, and to achieve more favorable outcomes for them. This article systematically summarizes the prevention and management strategies for cardiovascular toxicity related with chemotherapy, radiotherapy, targeted therapy, and immunotherapy. In addition, it examines current trends in this emerging interdisciplinary field as well.